ClinicalTrials.Veeva

Menu
C

Cleveland Clinic | Cole Eye Institute

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Fluocinolone Acetonide
AU-011
Kenalog
triamcinolone acetonide

Parent organization

This site is a part of Cleveland Clinic

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration

Enrolling
Macular Neovascularization Secondary to Age-Related Macular Degeneration
Biological: 4D-150 IVT (3E10 vg/eye)
Biological: EYLEA® (aflibercept) Injection 2 mg (0.05mL)

The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary i...

Enrolling
Indeterminate Lesions
Ocular Melanoma
Device: Suprachoroidal Microinjector
Drug: Bel-sar

Trial sponsors

NeuroTherapia, Inc. logo
4
A
Aura Biosciences logo
National Institutes of Health (NIH) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems